ALT Latest Headlines

Enovix, Serve Robotics, EOG, Altimmune, Globalstar Shake Markets

at www.tipranks.com (Sat, 10-Jan 8:01 AM)

Insider Move: Altimmune Director Makes Bold New Stock Purchase

at www.tipranks.com (Fri, 9-Jan 9:01 PM)

FDA Breakthrough for Altimmune: Pemvidutide Shows Statistically Significant Improvements in MASH Patients

Market Chameleon (Mon, 5-Jan 10:32 AM)

ALT’s Pemvidutide Shows Significant Antifibrotic Benefits at 48 Weeks: Phase 2b Results Point Toward Phase 3 Trial

Market Chameleon (Mon, 22-Dec 10:19 AM)

ALT’s Pemvidutide Achieves Strong 48-Week Efficacy in MASH: Significant Reductions in Liver Fibrosis and Sustained Weight Loss Highlight Phase 2b Results

Market Chameleon (Fri, 19-Dec 7:06 AM)

ALT Announces CEO Transition as Pemvidutide Approaches Phase 3 Milestone

Market Chameleon (Mon, 1-Dec 8:12 AM)